Harms KL, Healy MA, Nghiem P, Sober AJ, Johnson TM, Bichakjian CK, et al. Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System. Ann Surg Oncol. 2016; 23(11): 3564–3571.

Sunshine JC, Jahchan NS, Sage J, ChoiJ. Are there Multiple Cells of Origin of Merkel Cell Carcinoma? Oncogene. 2018; 37(11): 1409–1416.

McEvoy AM, LachancenK, Hippe DS, Cahill K, Moshiri Y, Lewiset CW, et al. Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time from Diagnosis. JAMA Dermatol. 2022; 158(4): 382–389.

Angeles CV, Sabel MS. Immunotherapy for Merkel cell carcinoma. J Surg Oncol. 2021;123(3):775–81.

Article  CAS  PubMed  Google Scholar 

Duarte-Bateman D, Shen A, Bullock T, Sadeghi P, Escandón JM, Dedkova E, et al. Best practices in surgical and nonsurgical managementof head and neck Merkel cell carcinoma: An update. Mol Carcinog. 2023;62(1):101–12.

Article  CAS  PubMed  Google Scholar 

Pozzi V, Campagna R, Sartini D, Emanuelli M. Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms. Biomolecules. 2022;12(9):1173.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang W, Yang C, Wang T, Deng H. Complex roles of nicotinamide N-methyltransferase in cancer progression. Cell Death Dis. 2022;13(3):267.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sartini D, Molinelli E, Pozzi V, Campagna R, Salvolini E, Rubini C, et al. Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma. Hum Cell. 2023;36(1):480–2.

Article  CAS  PubMed  Google Scholar 

Campagna R, Pozzi V, Spinelli G, Sartini D, Milanese G, Galosi AB, et al. The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update. Biomolecules. 2021;11(8):1214.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li XY, Pi YN, Chen Y, Zhu Q, Xia BR. Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy. Front Oncol. 2022;12:894744.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Togni L, Mascitti M, Sartini D, Campagna R, Pozzi V, Salvolini E, et al. Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review. Biomolecules. 2021;11(11):1594.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ganzetti G, Sartini D, Campanati A, Rubini C, Molinelli E, Brisigotti V, et al. Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma. Melanoma Res. 2018;28(2):82–8.

Article  CAS  PubMed  Google Scholar 

Pompei V, Salvolini E, Rubini C, Lucarini G, Molinelli E, Brisigotti V, et al. Nicotinamide N-methyltransferase in nonmelanoma skin cancers. Eur J Clin Invest. 2019;49:e13175.

Article  CAS  PubMed  Google Scholar 

Leonard JH, Dash P, Holland P, Kearsley KH, Bell JR. Characterisation of four Merkel cell carcinoma adherent cell lines. Int J Cancer. 1995;60(1):100–7.

Article  CAS  PubMed  Google Scholar 

Van Gele M, Leonard JH, Van Roy N, Van Limbergen H, Van Belle S, Cocquyt V, et al. Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma. Int J Cancer. 2002;101(2):137–45.

Article  PubMed  Google Scholar 

Campagna R, Salvolini E, Pompei V, Pozzi V, Salvucci A, Molinelli E, et al. Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines. Pigment Cell Melanoma Res. 2021;34(6):1039–48.

Article  CAS  PubMed  Google Scholar 

Coggshall K, Tello TL, North JP, Yu SS. Merkel cell carcinoma: an update and review: pathogenesis, diagnosis, and staging. J Am Acad Dermatol. 2018;78(3):433–42.

Article  PubMed  Google Scholar 

Walsh NM, Cerroni L. Merkel cell carcinoma: A review. J Cutan Pathol. 2021;48(3):411–21.

Article  PubMed  Google Scholar 

Zwijnenburg EM, Lubeek SFK, Werner JEM, et al. Merkel cell carcinoma: New trends. Cancers (Basel). 2021;13(7):1614.

Article  CAS  PubMed  Google Scholar 

Patel P, Hussain K. Merkel cell carcinoma. Clin Exp Dermatol. 2021;46(5):814–9.

Article  CAS  PubMed  Google Scholar 

Aksoy S, Szumlanski CL, Weinshilboum RM. Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. J Biol Chem. 1994; 269: 14835–14840.

Peng Y, Sartini D, Pozzi V, Wilk D, Emanuelli M, Yee VC. Structural basis of substrate recognition in human nicotinamide N-methyltransferase. Biochemistry. 2011;50:7800–8.

Article  CAS  PubMed  Google Scholar 

Campagna R, Cecati M, Pozzi V, Fumarola S, Pompei V, Milanese G, et al. Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma. Cell Mol Biol (Noisy-le-grand). 2018; 64(7): 51–55.

Sartini D, Morganti S, Guidi E, Rubini C, Zizzi A, Giuliante R, et al. Nicotinamide N-methyltransferase in Non-small Cell Lung Cancer: Promising Results for Targeted Anti-cancer Therapy. Cell Biochem Biophys. 2013;67:865–73.

Article  CAS  PubMed  Google Scholar 

Campagna R, Pozzi V, Sartini D, Salvolini E, Brisigotti V, Molinelli E, et al. Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N-Methyltransferase as a Biomarker in Skin Cancers. Cancers (Basel). 2021;13(19):4943.

Article  CAS  PubMed  Google Scholar 

Zhang J, Wang Y, Li G, Yu H, Xie X. Down-regulation of nicotinamide N-methyltransferase induces apoptosis in human breast cancer cells via the mitochondria-mediated pathway. PLoS ONE. 2014;9:e89202.

Article  PubMed  PubMed Central  Google Scholar 

Xie X, Yu H, Wang Y, Zhou Y, Li G, Ruan Z, et al. Nicotinamide N-methyltransferase enhances the capacity of tumorigenesis associated with the promotion of cell cycle progression in human colorectal cancer cells. Arch Biochem Biophys. 2014;564:52–66.

Article  CAS  PubMed  Google Scholar 

Xie X, Liu H, Wang Y, Zhou Y, Yu H, Li G, et al. Nicotinamide N-methyltransferase enhances resistance to 5-fluorouracil in colorectal cancer cells through inhibition of the ASK1-p38 MAPK pathway. Oncotarget. 2016;7:45837–48.

Article  PubMed  PubMed Central  Google Scholar 

Win KT, Lee SW, Huang HY, Lin LC, Lin CY, Hsing CH, et al. NicotinamideN-methyltransferase overexpression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma. Tumour Biol. 2013;34:3923–31.

Article  CAS  PubMed  Google Scholar 

Wu Y, Siadaty MS, Berens ME, Hampton GM, Theodorescu D. Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration. Oncogene. 2008;27:6679–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang SW, Yang TC, Lin WC, Lin WC, Chang WH, Wang CC, Lai MK, et al. Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells. Carcinogenesis. 2011;32:138–45.

Article  CAS  PubMed  Google Scholar 

Yu T, Wang YT, Chen P, Li YH, Chen YX, Zenget H, al. Effects of nicotinamide N-methyltransferase on PANC-1 cells proliferation, metastatic potential and survival under metabolic stress. Cell Physiol Biochem. 2015; 35: 710–721.

Chen C, Wang X, Huang X, Yong H, Shen J, Tang Q, et al. Nicotinamide N-methyltransferase: a potential biomarker for worse prognosis in gastric carcinoma. Am J Cancer Res. 2016;6:649–63.

CAS  PubMed  PubMed Central  Google Scholar 

Parsons RB, Aravindan S, Kadampeswaran A, Evans EA, Sandhu KK, Levy ER, et al. The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of complex I inhibitors. Biochem J. 2011;436:145–55.

Article  CAS  PubMed  Google Scholar 

Zhou W, Gui M, Zhu M, Long Z, Huang L, Zhou J, et al. Nicotinamide Nmethyltransferase is overexpressed in prostate cancer and correlates with prolonged progression-free and overall survival times. Oncol Lett. 2014;8:1175–80.

Article  PubMed  PubMed Central  Google Scholar 

Bach D, H Kim D, Bae SY, Kim WK, Hong JY, Lee HJ et al. Targeting nicotinamide N-methyltransferase and miR-449a in EGFR-TKI-resistant non-small-cell lung cancer cells. Molecular Therapy -Nucleic Acids. 2018; 11: 455–467.

You Z, Liu Y, Liu X. Nicotinamide N-methyltransferase enhances the progression of prostate cancer by stabilizing sirtuin. Oncol Lett. 2018;15:9195–201.

PubMed  PubMed Central  Google Scholar 

Cui Y, Zhang L, Wang W, Ma S, Liu H, Zang X, et al. Downregulation of nicotinamide N-methyltransferase inhibits migration and epithelial-mesenchymal transition of esophageal squamous cell carcinoma via Wnt/β-catenin pathway. Mol Cell Biochem. 2018;460:93–103.

Article  Google Scholar 

Sartini D, Seta R, Pozzi V, Morganti S, Rubini C, Zizzi A, et al. Role of nicotinamide N-methyltransferase in non-small cell lung cancer: In vitro effect of shRNA-mediated gene silencing on tumourigenicity. Biol Chem. 2015;396(3):225–34.

Article  CAS  PubMed  Google Scholar 

Pozzi V, Sartini D, Morganti S, Giuliante R, Di Ruscio G, Santarelli A, et al. RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells. PLoS ONE. 2013;8: e71272.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seta R, Mascitti M, Campagna R, Sartini D, Fumarola S, Santarelli A, et al. Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: Effect on apoptosis and cell proliferation. Clin Oral Invest. 2019;23:829–38.

Article